Skip to content

Spyre Therapeutics, Inc. SYRE Segment Reporting Other Item Amount

Segment Reporting Other Item Amount at other companies

Protagonist Therapeutics logo
Protagonist TherapeuticsPTGX
-$53K+35.4%
Essential Utilities logo
Essential UtilitiesWTRG
-$75K+74.4%
Atmos Energy logo
Atmos EnergyATO
$1.01B-7.3%
SiTime Corporation logo
SiTime CorporationSITM
$71.86M+26.2%
ConocoPhillips logo
ConocoPhillipsCOP
$7.22B+6.1%
Cleveland-Cliffs logo
Cleveland-CliffsCLF
$2M

Segments

By segment

See full
Reportable Segment-$2.14M+53.8%

Other financials

Income statement

See full
Revenue-
Operating income-$45.6M+14.8%
Net income-$69.0M-54.1%
EPS (diluted)-$0.74-23.3%

Balance sheet

See full
Cash & equivalents$97.2M+100%
Total debt$4.3M-9.6%
Total equity$670.8M+39.0%
Total assets$764.0M+34.1%

Cash flow

See full
Operating cash flow-$57.4M-40.0%
CapEx-
Free cash flow-$39.4M-26.8%

Valuation

See full
Market cap$7.67B+307%

Profitability

See full
Operating margin-39,428.9%-49,795pp
Net margin-52,939.7%-61,871pp
FCF margin-3,442.8%-3,807pp

Returns & leverage

See full
Return on equity-31.1%-10.7pp
Debt / equity0.1×+0.1×
Current ratio+0.9×